1. The in vivo antitumor effects of type I-interferon against hepatocellular carcinoma: the suppression of tumor cell growth and angiogenesis
   Hirayuki Enomoto et al, 2017, Scientific Reports CrossRef
2. Therapeutic efficacy of sorafenib and plant-derived phytochemicals in human colorectal cancer cells
   Abdulmajeed Bahman et al, 2023, BMC Complementary Medicine and Therapies CrossRef
3. Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells
   Ha Ra Gu et al, 2015, Clinical and Molecular Hepatology CrossRef
4. Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery
   Nayab Tahir et al, 2020, International Journal of Pharmaceutics CrossRef
5. Pegylated interferon-α inhibits the proliferation of hepatocellular carcinoma cells by downregulating miR-155
   Ying Zhang et al, 2019, Annals of Hepatology CrossRef
6. Growth inhibitory effect of an injectable hyaluronic acid–tyramine hydrogels incorporating human natural interferon-α and sorafenib on renal cell carcinoma cells
   Kosuke Ueda et al, 2016, Acta Biomaterialia CrossRef
7. Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study
   Norio Itokawa et al, 2016, International Journal of Clinical Oncology CrossRef
8. The effects of silibin administration for different time periods on mouse liver with Ehrlich ascites carcinoma
   Alisa Bahar Beydogan et al, 2016, Pharmacological Reports CrossRef
9. Anti-tumor effect of ribavirin in combination with interferon-α on renal cell carcinoma cell lines in vitro
   Lichen Teng et al, 2014, Cancer Cell International CrossRef
10. Synergy with interferon-lambda 3 and sorafenib suppresses hepatocellular carcinoma proliferation
    Yuke Yan et al, 2017, Biomedicine & Pharmacotherapy CrossRef
11. Mechanism of action and treatment of type I interferon in hepatocellular carcinoma
    Chunxiu Peng et al, 2023, Clinical and Translational Oncology CrossRef
12. Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review)
    CHAOHUI ZUO et al, 2015, Oncology Letters CrossRef
13. Tiam1 siRNA enhanced the sensitivity of sorafenib on esophageal squamous cell carcinoma in vivo
    Huaimin Liu et al, 2014, Tumor Biology CrossRef